Florida Fines 12 Pharmacy Benefit Managers Over $12M
State market conduct exams under a 2023 law produced fines against PBMs over pricing and contract practices.
Updated on Nov. 17, 2026 in Healthcare

Live Poll
Do you trust pharmacy benefit managers to pass drug savings on to you?
Florida regulators have issued more than $12 million in fines to 12 pharmacy benefit managers over the last 12 months following market conduct examinations. The fines stem from PBM pricing models, unilateral changes to pharmacy contracts, and alleged statutory violations, and most of the PBMs have accepted the findings and begun correcting deficiencies.
Why it matters
The exams are conducted under Florida Senate Bill 1550, the Prescription Drug Reform Act, and reflect growing national scrutiny of PBMs over alleged lack of transparency and practices that squeeze pharmacies and raise consumer costs. Capital Rx, now Judi Rx and part of Judi Health, disputes nearly all of the regulator's findings, leaving those contested questions open.
Florida's Office of Insurance Regulation fined 12 PBMs more than $12 million, including $2.4 million against Employee Health Insurance Management, $2.2 million against Scrip World (owned by CVS Health), $2.1 million against Right Rx FL and $1.6 million against Capital RX Inc. Examiners found network adequacy terms missing from 19% of reviewed Capital Rx contracts, a finding the company contests.
The players
Florida Office of Insurance Regulation
The state agency responsible for regulating insurance in Florida, which conducts market conduct examinations of pharmacy benefit managers under the Prescription Drug Reform Act.
Capital Rx
A pharmacy benefit manager, now operating as Judi Rx and part of Judi Health, that disputed nearly all of the regulator's findings against it.
Scrip World
A pharmacy benefit management company owned by CVS Health, which was fined $2.2 million by Florida regulators.
Employee Health Insurance Management
A pharmacy benefit manager that received the largest fine in the Florida examinations, at $2.4 million.
Michael Yaworsky
A Florida public official quoted in connection with the state's regulatory oversight of pharmacy benefit managers.
The details
Examiners reviewed PBM contracts to determine whether statutorily required terms were included, and the Office of Insurance Regulation issued findings in market conduct exam reports that PBMs could accept or dispute. Most PBMs accepted the findings and have taken steps to correct deficiencies, while Capital Rx disagreed with almost all of the eight red flags raised in its August 28 report.
Timeline
2023: Florida Senate Bill 1550, the Prescription Drug Reform Act, was signed into law, authorizing regulator examinations of PBMs.
August 28, 2026: The Office of Insurance Regulation issued its market conduct exam report with eight red flags against Capital Rx.
Over the last 12 months: Market conduct exams resulted in more than $12 million in fines.
Market Landscape
Florida's fines come from examinations authorized by Senate Bill 1550, a 2023 law that gave the Office of Insurance Regulation authority to examine PBMs every two years. The enforcement reflects a broader national push to scrutinize how PBMs set pricing and modify pharmacy contracts.
Pharmacy benefit manager contract terms and pricing models shape what pharmacies are paid and what patients pay at the counter. Florida's enforcement may lead to corrected contract terms for some PBM customers, though the outcome of Capital Rx's disputed findings is not yet known.
The takeaway
Oversight of pharmacy benefit managers is shifting from voluntary practice toward recurring, statute-backed examinations. Readers following drug pricing should watch whether disputed findings are resolved and whether other states adopt similar examination schedules.
Further reading
For related coverage, explore Healthcare news on Florida's regulatory landscape.
Source note: This article includes information reported by Insurance Journal.
Live Poll
Do you trust pharmacy benefit managers to pass drug savings on to you?










